Replies to post #323 on RespireRx Pharmaceuticals Inc (RSPI)

[DewDiligence]

>…plus the generic company Teva (very well run company and they're buying competitor Ivax). I'm beginning to see the logic in some of Dew's picks (I think he likes Teva and Imclone).<

TEVA is a great company, but it’s not quite the screaming buy in the high 30’s that it was in the 20’s nine months ago (#msg-5470929, #msg-5471939). If your intention is buy and hold to build a LT core holding, I’d recommend some kind of dollar-cost-averaging system. Regards, Dew

[gfp927z]

The next time Dew comes cruising by this thread, perhaps he'll give us some insights on ESLT and GPCB, which are two companies he mentions in his I-Hub profile. ESLT is an Israeli high tech company which looks extremely interesting. GPCB looks like a German biotech involved with Spectrum Pharma on their cancer drug Satraplin. I'd be very interested in getting Dew's take on these and on any other stocks he currently likes.